|
FDA Issues Strictest Warning on Prescription Diabetes Drug Avandia
On June 6, 2007, the Food and Drug Administration (FDA) called for the most
stringent warning to be added to prescription Type 2 diabetes drug
Avandia.
The decision was revealed before a packed Congressional House
hearing. It comes, however, more than a year after FDA safety reviewers strongly
recommended that the agency take such a step.
In effect, the decision
tells GlaxoSmithKline, manufacturer of Avandia, to make the warning about
Avandia's heart risks more prominent, by placing it in a so-called "black box."
According to the New York Times, the call for this heightened
warning is due to the fact that "despite existing warnings, these drugs
[[diabetes drugs Avandia and Actos, the latter made by Eli Lilly]] were being
prescribed to patients with significant heart failure."
The article
quotes Representative Henry Waxman, a California Democrat who is chairman of the
House Committee on Oversight and Government Reform as saying, "Avandia is a case
study of the need for reform of our drug safety laws."
If you or a loved
one has suffered cardiac complications after ingesting Avandia, you deserve the
guidance of an experienced drug attorney. Get a free case review by filling out
the form below.
see also:
Black Box Warning
FDA: Manufacturer of Avandia Strengthens Warning on Heart Failure RiskFDA Says GlaxoSmithKline Will Include Boxed Warning on Avandia Label
FDA Warning, 5.22.07
FDA Alert on the Anti-Diabetes Drug Avandia: Risk of Heart AttackRisks to taking the drug Avandia include heart attack and chest pain
Scientists Silenced
Scientists Silenced About the Dangers of Avandia--Attorney ResourcesEditorial: Scientists Silenced About Avandia--Get an Avandia Attorney
